Transcatheter Pulmonary Valve Implantation is used to repair a stenosed or regurgitant pulmonary heart valve that has previously been replaced to correct congenital heart defects. This technology provides a less-invasive means to extend the life of a failed Right Ventricular Outflow Tract (RVOT) conduit.
Transcatheter Pulmonary Valve Implantation may be considered medically necessary for use as an adjunct to surgery in the management of pediatric and adult individuals in accordance with the Humanitarian Device Exemption (HDE) specifications of the U.S. Food and Drug Administration (FDA) for the treatment of patients with the following FDA approved clinical conditions:
Services that do not meet the above criteria are not considered medically necessary.
33477 |
I37.0 | I37.1 | I37.2 | I37.8 | I37.9 | I97.0 | I97.110 |
I97.130 | I97.190 | Q20.5 | Q21.3 | Q22.0 | Q22.1 | Q22.2 |
Q22.3 | T82.01XA | T82.01XD | T82.01XS | T82.02XA | T82.02XD | T82.02XS |
T82.03XA | T82.03XD | T82.03XS | T82.09XA | T82.09XD | T82.09XS | T82.221A |
T82.221D | T82.221S | T82.222A | T82.222D | T82.222S | T82.223A | T82.223D |
T82.223S | T82.228A | T82.228D | T82.228S | T82.857A | T82.857D | T82.857S |
T82.897A | T82.897D | T82.897S | T82.9XXA | T82.9XXD | T82.9XXS | Z87.74 |
Z95.2 | Z95.3 | Z95.4 |